Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy.
Clinical trial NCT01941329 · COMPLETED
Trial details
- NCT number
- NCT01941329
- Sponsor
- Association for Innovation and Biomedical Research on Light and Image
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2016-04-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.